1. Home
  2. AIHS vs NRSN Comparison

AIHS vs NRSN Comparison

Compare AIHS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.40

Market Cap

19.8M

Sector

Finance

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.53

Market Cap

16.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
NRSN
Founded
2014
2017
Country
China
Israel
Employees
N/A
16
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.8M
16.8M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AIHS
NRSN
Price
$1.40
$0.53
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
77.7K
177.1K
Earning Date
02-13-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,546,127.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.39
52 Week High
$8.26
$1.33

Technical Indicators

Market Signals
Indicator
AIHS
NRSN
Relative Strength Index (RSI) 54.10 N/A
Support Level $1.12 N/A
Resistance Level $1.58 N/A
Average True Range (ATR) 0.16 0.00
MACD 0.00 0.00
Stochastic Oscillator 77.50 0.00

Price Performance

Historical Comparison
AIHS
NRSN

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: